Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathway

Molecular Endocrinology

Volumn 24, Issue 9, 2010, Pages 1782-1793

  Palaniappan, Murugesan ^a   Menon, K M J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CHORIONIC GONADOTROPIN; CYCLIC AMP; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; FORSKOLIN; LUTEINIZING HORMONE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN S6; RAPAMYCIN; S6 KINASE; SMALL INTERFERING RNA; TUBERIN;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HORMONE ACTION; LEYDIG CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; THECA CELL; UPREGULATION;

ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CHORIONIC GONADOTROPIN; CYCLIC AMP; CYCLIN D1; CYCLIN D3; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RIBOSOMAL PROTEIN S6; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIROLIMUS; THECA CELLS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EUKARYOTA; MAMMALIA;

EID: 77956097751     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0044     Document Type: Article

References (55)

1. Magoffin DA 2002 The ovarian androgen-producing cells: a 2001 perspective. Rev Endocr Metab Disord 3:47-53
2. Magoffin DA 2005 Ovarian theca cell. Int J Biochem Cell Biol 37:1344-1349
3. Leung PC, Steele GL 1992 Intracellular signaling in the gonads. Endocr Rev 13:476-498
4. Duleba AJ, Foyouzi N, Karaca M, Pehlivan T, Kwintkiewicz J, Behrman HR 2004 Proliferation of ovarian theca-interstitial cells is modulated by antioxidants and oxidative stress. Hum Reprod 19:1519-1524 (Pubitemid 38997174)
5. Spaczynski RZ, Tilly JL, Mansour A, Duleba AJ 2005 Insulin and insulin-like growth factors inhibit and luteinizing hormone augments ovarian theca-interstitial cell apoptosis. Mol Hum Reprod 11:319-324 (Pubitemid 41417864)
6. Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA 2001 Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 86:1318-1323 (Pubitemid 32323023)
7. Magoffin DA 2006 Ovarian enzyme activities in women with polycystic ovary syndrome. Fertil Steril 86(Suppl 1):S9-S11
8. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
9. Azziz R 2003 Androgen excess is the key element in polycystic ovary syndrome. Fertil Steril 80:252-254 (Pubitemid 36959774)
10. Richards JS 2001 New signaling pathways for hormones and cyclic adenosine 3′,5′- monophosphate action in endocrine cells. Mol Endocrinol 15:209-218
11. Wood JR, Strauss 3rd JF 2002 Multiple signal transduction pathways regulate ovarian steroidogenesis. Rev Endocr Metab Disord 3:33-46 (Pubitemid 34693403)
12. Hunzicker-Dunn M, Maizels ET 2006 FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal 18:1351-1359 (Pubitemid 43832089)
13. Alam H, Maizels ET, Park Y, Ghaey S, Feiger ZJ, Chandel NS, Hunzicker-Dunn M 2004 Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem 279:19431-19440 (Pubitemid 38623376)
14. Arvisais EW, Romanelli A, Hou X, Davis JS 2006 AKT-independent phosphorylation of TSC2 and activation of mTOR and ribosomal protein S6 kinase signaling by prostaglandin F2α. J Biol Chem 281:26904-26913 (Pubitemid 44401719)
15. Kayampilly PP, Menon KMJ 2007 Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells. Endocrinology 148:3950-3957
16. Gonzalez-Robayna IJ, Falender AE, Ochsner S, Firestone GL, Richards JS 2000 Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/AKT) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells. Mol Endocrinol 14:1283-1300 (Pubitemid 32260488)
17. Zeleznik AJ, Saxena D, Little-Ihrig L 2003 Protein kinase B is obligatory for follicle-stimulating hormone-induced granulosa cell differentiation. Endocrinology 144:3985-3994 (Pubitemid 37088754)
18. Andric N, Ascoli M 2006 A delayed gonadotropin-dependent and growth factor-mediated activation of the extracellular signal-regulated kinase 1/2 cascade negatively regulates aromatase expression in granulosa cells. Mol Endocrinol 20:3308-3320 (Pubitemid 44833573)
19. Tajima K, Yoshii K, Fukuda S, Orisaka M, Miyamoto K, Amsterdam A, Kotsuji F 2005 Luteinizing hormone-induced extracellular-signal regulated kinase activation differently modulates progesterone and androstenedione production in bovine theca cells. Endocrinology 146:2903-2910 (Pubitemid 41002797)
20. Carvalho CR, Carvalheira JB, Lima MH, Zimmerman SF, Caperuto LC, Amanso A, Gasparetti AL, Meneghetti V, Zimmerman LF, Velloso LA, Saad MJ 2003 Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/AKT pathways. Endocrinology 144:638-647
21. Robker RL, Richards JS 1998 Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol 12: 924-940
22. Guertin DA, Sabatini DM 2007 Defining the role of mTOR in cancer. Cancer Cell 12:9-22
23. Inoki K, Ouyang H, Li Y, Guan KL 2005 Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev 69:79-100 (Pubitemid 40358068)
24. Tee AR, Blenis J 2005 mTOR, translational control and human disease. Semin Cell Dev Biol 16:29-37 (Pubitemid 40126874)
25. Ma XM, Blenis J 2009 Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10:307-318
26. Fingar DC, Salama S, Tsou C, Harlow E, Blenis J 2002 Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16:1472-1487 (Pubitemid 34686329)
27. Ruvinsky I, Meyuhas O 2006 Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 31:342-348 (Pubitemid 43903237)
28. Hay N, Sonenberg N 2004 Upstream and downstream of mTOR. Genes Dev 18:1926-1945
29. Richardson CJ, Schalm SS, Blenis J 2004 PI3-kinase and TOR: PIKTORing cell growth. Semin Cell Dev Biol 15:147-159 (Pubitemid 38251643)
30. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J 2002 Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 99:13571-13576 (Pubitemid 35215423)
31. Manning BD, Cantley LC 2003 United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/AKT pathway to mammalian target of rapamycin (mTOR) signalling. Biochem Soc Trans 31:573-578
32. Inoki K, Corradetti MN, Guan KL 2005 Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 37:19-24 (Pubitemid 40070934)
33. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR, Roberts JM 1994 Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372 :570-573 (Pubitemid 2164735)
34. Withers DJ, Seufferlein T, Mann D, Garcia B, Jones N, Rozengurt E 1997 Rapamycin dissociates p70(S6K) activation from DNA synthesis stimulated by bombesin and insulin in Swiss 3T3 cells. J Biol Chem 272:2509-25014 (Pubitemid 27058543)
35. Xu Y, Chen SY, Ross KN, Balk SP 2006 Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res 66:7783-7792 (Pubitemid 44289239)
36. Fingar DC, Blenis J 2004 Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151-3171 (Pubitemid 38638827)
37. Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung RS, Ru B, Pan D, Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung RS, Ru B, Pan D 2002 Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 4:699-704 (Pubitemid 34993706)
38. Goncharova EA, Goncharov DA, Eszterhas A, Hunter DS, Glassberg MK, Yeung RS, Walker CL, Noonan D, Kwiatkowski DJ, Chou MM, Panettieri Jr RA, Krymskaya VP 2002 Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem 277:30958-30967
39. Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, el-Hashemite N, Onda H 2002 A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet 11:525-534
40. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J 2002 Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 99:13571-13576
41. Wood JR, Nelson-Degrave VL, Jansen E, McAllister JM, Mosselman S, Strauss 3rd JF 2005 Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. Physiol Genomics 20:233-243
42. Inoki K, Li Y, Zhu T, Wu J, Guan KL 2002 TSC2 is phosphorylated and inhibited by AKT and suppresses mTOR signalling. Nat Cell Biol 4:648-657
43. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC 2002 Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/AKT pathway. Mol Cell 10:151-162 (Pubitemid 34876569)
44. Potter CJ, Pedraza LG, Xu T 2002 AKT regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4:658-665 (Pubitemid 34993701)
45. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J 2004 mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 24:200-216 (Pubitemid 38010048)
46. Fingar DC, Salama S, Tsou C, Harlow E, Blenis J 2002 Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16:1472-1487 (Pubitemid 34686329)
47. Tee AR, Blenis J, Proud CG 2005 Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. FEBS Lett 579:4763-4768
48. Schmelzle T, Hall MN 2000 TOR, a central controller of cell growth. Cell. 103:253-262
49. Wullschleger S, Loewith R, Hall MN 2006 TOR signaling in growth and metabolism. Cell 124:471-484
50. Ruvinsky I, Meyuhas O 2006 Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 31:342-348 (Pubitemid 43903237)
51. Bandi HR, Ferrari S, Krieg J, Meyer HE, Thomas G 1993 Identification of 40 S ribosomal protein S6 phosphorylation sites in Swiss mouse 3T3 fibroblasts stimulated with serum. J Biol Chem 268:4530-4533 (Pubitemid 23073004)
52. Chou MM, Blenis J 1995 The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signaling. Curr Opin Cell Biol 7:806-814
53. Thomas G 2002 The S6 kinase signaling pathway in the control of development and growth. Biol Res 35:305-313 (Pubitemid 35189803)
54. Palaniappan M, Menon KMJ 2009 Regulation of sterol regulatory element binding transcription factor 1a by human chorionic gonadotropin and insulin in cultured rat theca-interstitial cells. Biol Reprod 81:284-292
55. Wu Q, Sucheta S, Azhar S, Menon KMJ 2003 Lipoprotein enhancement of ovarian theca-interstitial cell steroidogenesis: relative contribution of scavenger receptor class B (type I) and adenosine 5′-triphosphate- binding cassette (type A1) transporter in high-density lipoprotein-cholesterol transport and androgen synthesis. Endocrinology 144:2437-2445 (Pubitemid 36629895)